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Abstract The effect of functionalized nickel (Ni) nano-
particles capped with positively charged tetraheptylammoni-
um on cellular uptake of drug quercetin into hepatocellular
carcinoma cells (SMMC-7721) has been explored in this
study via microscopy and electrochemical characterization as
well as MTT assay. Meanwhile, the inﬂuence of Ni nano-
particles and/or quercetin on cell proliferation has been
further evaluated by the real-time cell electronic sensing (RT-
CES) study. Our observations indicate that Ni nanoparticles
could efﬁciently improve the permeability of cancer cell
membrane, and remarkably enhance the accumulation of
quercetin in SMMC-7721 cells, suggesting that Ni nanopar-
ticles and quercetin would facilitate the synergistic effect on
inhibiting proliferation of cancer cells.
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Introduction
With the development of nanotechnology, nanomateri-
als are now widely produced and applied in biomedical
and biologic engineering [1–4]. Due to their unique
characteristics, nanomaterials and nanotechnologies are
changing many basic scientiﬁc concepts in a great variety of
ﬁelds, and are receiving intensively increasing interest in
the relative research and industrial applications.
It is well known that the efﬁciency of many conventional
pharmaceutical therapies can be signiﬁcantly improved
through the drug delivery system (DDS). DDS could be
designed to alter the pharmacokinetics and biodistribution
of their associated drugs and/or to function as drug reser-
voirs [5]. Some biocompatible nanoparticles, such as gold
nanoparticles, iron oxide nanoparticles, have been used in
DDS because of their feasibility to produce, characterize,
and speciﬁcally tailor their functional properties [6–9].
Flavonoids are plant metabolites that are dietary anti-
oxidants and exert signiﬁcant antiallergic and antiviral
effects. Quercetin is one of the most abundant ﬂavonoids in
the human diet and has been associated with a large
number of biologic activities, many of which may con-
tribute to the prevention of human diseases due to their
effects of antihypertensive, antiinﬂammatory, and anticar-
diovascular disease [10–13]. Recently, an increasing
number of reports have shown that quercetin has multiple
effects on cancer cells, which can induce the apoptosis of
cancer cells to exert the antitumor effect [14–16]. Addi-
tionally, the electrochemical assays for quercetin have been
extensively studied due to its sensitive electroactive prop-
erty [17–20]. Based on these observations, in this study we
have utilized electrochemical strategy in the quantitative
analysis of quercetin in the cellular systems; meanwhile,
the relevant effects of functionalized nickel (Ni) nanopar-
ticles on cellular uptake of drug quercetin into SMMC-
7721 cancer cells have also been explored by means of
atomic force microscopy (AFM), ﬂuorescence microscopy
and electrochemical assay. The result of our studies has
afforded the ﬁrst evidence that the functionalized Ni
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lammonium could improve the permeability of hepatocel-
lular carcinoma cell membrane, and remarkably enhance
the accumulation of quercetin in SMMC-7721 cells.
Meanwhile, the real-time cell electronic sensing (RT-CES)
assay also provides the dynamic information that could be
used to identify the interaction between cells and chemi-
cals. The RT-CES array has proven valuable, sensitive and
reliable for real time monitoring of dynamic changes
induced by cell–chemical interaction [21–23]. During the
RT-CES assay, the electrode sensor array was specially
designed and integrated onto the bottom of a standard
microtiter plate and cells directly grow on the sensor sur-
face. The basic principle of the RT-CES system is to
monitor the changes in electrode impedance induced by the
interaction between testing cells and electrodes, where the
presence of the cells will lead to an increase in the elec-
trode impedance. The more cells attached to the sensor,
the higher the impedance that could be monitored with
RT-CES. Because the test is labeling free and quantitative,
the RT-CES assay allows real-time, automatically and
continually monitoring cellular status changes during the
whole process of the cell–chemical interaction. Accord-
ingly, in this study we have combined the MTT (3-(4,
5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide)
assay with RT-CES study [24]. Initially, we have explored
the in vitro effect of quercetin in the absence and presence
of Ni nanoparticles on SMMC-7721 cancer cells (a hepa-
tocellular carcinoma cell line) by MTT assay, while the
dynamic response of cancer cells exposure to Ni nano-
particles and/or quercetin has been determined by the
RT-CES system. Our results demonstrate that Ni nano-
particles can readily facilitate the cellular drug uptake of
quercetin into cancer cells and enhance the cytotoxicity
suppression of quercetin on the proliferation of cancer
cells, indicating their great potential in clinical and bio-
medical applications.
Experimental Section
Preparation and Characterization of Ni Nanoparticles
The fabrication of the Ni nanoparticles capped with posi-
tively charged tetraheptylammonium and the transmission
electron microscopy image are similar to that we previously
reported in the literature [25]. Brieﬂy, the Ni nanoparti-
cles capped with tetraheptylammonium were produced by
electrochemical deposition, where the electrolysis pro-
cesses were carried out in a 0.1 M tetraheptylammonium
2-propanol solution using an anode of high-purity Ni-sheets
and a cathode of glassy carbon. For the electrolysis, a cur-
rent density of 10–40 mA cm
-2 was applied. The deposited
clusters were capped with positively charged tetrahepty-
lammonium. The functionalized Ni nanoparticles were
characterized by TEM, and the average size was about
30 nm, as shown in Fig. 1.
Cell Culture
SMMC-7721 cancer cells (purchased from Shanghai
Institutes for Biological Sciences, Chinese Academy of
Sciences) were maintained in RPMI-1640 medium (Gibco,
USA) supplemented with 10% fetal bovine serum (Sigma,
USA), 100 U/ml penicillin (Sigma, USA), and 100 lg/ml
streptomycin (Sigma, USA), and grown at 37 Ci na5 %
CO2 humidiﬁed environment.
Morphological Assay of Cells Treated with Ni
Nanoparticles
The SMMC-7721 cells were plated on coverlips in 6-well
plates (10
5 cells/well) and treated with different concen-
tration of Ni nanoparticles. The concentrations of Ni
nanoparticles cocultured with cells for optical microscopy
assay were 3.12, 12.5 and 50 lg/mL, respectively, and
cultured in the incubator for 72 h at 37 C with 5% CO2;
while the concentration of Ni nanoparticles cocultured with
cells for AFM assay was 12.5 lg/mL and incubated for 6 h
at 37 Cw i t h5 %C O 2. After treatment, the cells were
observed by optical microscopy (Olympus BX 51, Japan)
and atomic force microscopy (AFM, SPI 3800N, Japan).
Fig. 1 Typical TEM image of the functionalized Ni nanoparticle.
The average size of Ni nanoparticles was about 30 nm. Bar 100 nm
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The experiment was performed as described in the literature
[26]. The SMMC-7721 cells were seeded on the coverlips in
6-well plates (10
5 cells/well) and cultured for 24 h at 37 C
with 5% CO2, then both quercetin and Ni nanoparticles
were injected to cells and their concentrations were 5.0 and
2.0 lg/mL, respectively. Meanwhile, the cells treated with
the same concentration of quercetin were taken as control
experiments. All specimens were subsequently incubated
for 1 h at 37 C with 5% CO2, quickly washed with PBS,
and then was followed by ﬁxation with 4% formaldehyde
for 5 min. Finally, specimens were observed by inverted
ﬂuorescence microscopy (Olympus IX71, Japan).
Electrochemical Study
SMMC-7721 cell suspensions (8 9 10
5 cells/mL) contain-
ing 50 lmol/L of quercetin were cultured in the absence
and presence of 2.0 lg/mL of Ni nanoparticles at room
temperature (22 ± 2 C) for 2 and 6 h, respectively. All
samples were diluted with sterile phosphate buffer saline
(PBS, 100 mmol/L, pH 7.2). The electrochemical signal
was determined with differential pulse voltammetry (DPV)
assay for each sample by CHI660C electrochemical
analyzer. All measurements were carried out in a three-
component electrochemical cell consisting of a glassy
carbon electrode as the working electrode, a Pt wire as the
counter electrode and a saturated calomel electrode as the
reference electrode.
MTT Assay
The effect of different quercetin concentrations on SMMC-
7721 cancer cells in the absence and presence of Ni
nanoparticles was carried out by MTT assay. The ﬁnal
concentrations of quercetin and Ni nanoparticles were 25
(or 50) and 2.0 lg/mL, respectively. Initially, 1 9 10
4 cells
were seeded into each well containing 200 lL cell culture
medium in 96-well plates and incubated for 24 h, then the
relevant chemicals were added and incubated at 37 C with
5% CO2 for 72 h. Controls were cultivated under the same
condition without addition of quercetin and/or the Ni
nanoparticles. The relevant experiments were repeated
thrice independently. The inhibition efﬁciency (%) was
expressed as follows: (1-[A]test/[A]control) 9 100, where
[A]test and [A]control represent the optical density at 540 nm
for the test and control experiments, respectively.
In vitro RT-CES Cytotoxicity Assay
The cell culture condition, the starting cell number and cell
culture medium volume used for the 169 sensor device
were similar to that of MTT assay. About 50 lmol/L of
quercetin in the absence and presence of 2.0 lg/mL of Ni
nanoparticles were seeded in the plate. The relevant con-
trols were also seeded in the same plate simultaneously.
Once the cells were added to the sensor wells, the sensor
devices were placed into the incubator and the real-time
cell index (CI) data acquisition was initiated by the RT-
CES analyzer (ACEA Bioscience. Inc., USA).
Statistics
Data were expressed as the means ± SD (standard devia-
tion) from at least three independent experiments. One-
tailed unpaired Student’s t-test was used for signiﬁcance
testing, and p\0.05 is considered signiﬁcant.
Results and Discussion
The Cellular Microscopical Morphology
Initially, the effect of the functionalized Ni nanoparticles on
SMMC-7721 cells has been studied by optical microscopy
and atomic force microscopy (AFM). In comparison with
the general morphology of SMMC-7721 cells in the
absence of Ni nanoparticles (Fig. 2a), the majority of
SMMC-7721 cells still grew well after an incubation of
72 h with 3.13 lg/mL Ni nanoparticles (Fig. 2b) and little
inﬂuence was observed for the cellular microscopical
morphology. However, when the concentration of Ni
nanoparticles increased to 12.5 lg/mL, only a portion of
SMMC-7721 cells could survive while their morphologies
had remarkable changes (Fig. 2c). It is noted that 50 lg/mL
of Ni nanoparticles could inhibit almost all SMMC-7721
cell proliferation (Fig. 2d). These results suggest that the
functionalized Ni nanoparticles could induce cell-cycle
arrest and increase apoptosis and/or necrosis to inhibit cell
proliferation at higher doses of nanoparticles, whereas it has
little effects on target cancer cells at lower doses.
AFM Assay
AFM is a surface analytical technique, which can image
the nanoscale topography by scanning across the surface.
As shown in Fig. 3, compared with the control experiments
without Ni nanoparticles (Fig. 3a), the AFM image cap-
tured after incubation for 6 h with 12.5 lg/mL of Ni
nanoparticles showed that cellular uptake of Ni nanopar-
ticles would lead to some holes generated on SMMC-7721
cells, just as the dark spots arrowed in Fig. 3b. The for-
mation of holes on the cell membrane induced by Ni
nanoparticles can alter the permeability of the respective
cell membrane and thus facilitate the relevant drug uptake
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cancer cells and thus could greatly inhibit the proliferation
of cancer cells.
Hence, these observations indicate that upon application
of these Ni nanoparticles at higher concentrations, the
relevant effect of Ni nanoparticles can efﬁciently produce
some holes and/or result in the release of the cytosol out of
the cancer cell and thus make the cell death, whereas at the
lower concentrations of Ni nanoparticles, the relevant Ni
nanoparticles have little effect on the cell morphology. The
Fig. 2 Morphological images
of SMMC-7721 cells treated
with or without Ni
nanoparticles. The SMMC-7721
cells grown on coverlips were
treated with different
concentrations of Ni
nanoparticles for 72 h,
respectively. The cancer cells
were washed with PBS, ﬁxed in
methanol, stained with Wright’s
solution and then photographed
(original magniﬁcation, 200). a
SMMC-7721 cells without Ni
nanoparticles (control
experiment); b SMMC-7721
cells treated with 3.13 lg/mL
of Ni nanoparticles; c SMMC-
7721 cells treated with 12.5
lg/mL of Ni nanoparticles, and
d SMMC-7721 cells treated
with 50 lg/mL of Ni
nanoparticles. Bar 10 lm
Fig. 3 AFM images for cell
uptake of Ni nanoparticles. a
SMMC-7721 cell without Ni
nanoparticles (control
experiment); and b the cell
surface after incubation with
12.5 lg/mL of Ni nanoparticles
for 6 h, which illustrates the
apparent uptake of Ni
nanoparticles during the process
of endocytosis that led to the
change of the cell membrane
and formation of holes (arrows)
on the surface of the relevant
cell
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nanoparticles could lead to the alteration of permeability of
cell membrane and facilitate the drug uptake of quercetin
into the cancer cells, which will further induce the apoptosis
and/or necrosis of cancer cells. Moreover, when the com-
bination with the anticancer drug quercetin, the lipid–lipid
afﬁnity of the lipid-soluble quercetin and the long alkane
groups of functionalized Ni nanoparticles may lead to the
formation of the relevant nanocomposites and make more
drug molecules readily enter into the cancer cell. Thus, it is
evident that in the presence of Ni nanoparticles, quercetin
could diffuse through the cell membrane holes created by
Ni nanoparticles or the Ni nanoparticles carrying a signiﬁ-
cant amount of quercetin into cells due to the surface con-
centrating effect. As shown in Scheme 1, the functionalized
Ni nanoparticles have positive charges and hydrophobic
groups, which could readily carry more drug molecule into
cancer cells. It has been reported that some polymers with
the greatest density of positively charged groups on the
chains show the most dramatic increase in membrane
thinning and membrane permeability, which could induce
the formation of holes on both supported lipid bilayers and
cellular membranes [27–29]. In our study, the effect of Ni
nanoparticles capped with positively charged tetrahepty-
lammonium on the cell membrane is also in favor of the
formation of holes (arrows, Fig. 3b), which will facilitate
the entry of drug into cell and increase the intracellular
accumulation of drug molecules in cancer cells.
Enhanced uptake of quercetin by Ni nanoparticles—
Fluorescence and electrochemical study
Thus, based on the above studies, we have further inves-
tigated the effective effect of the functionalized Ni nano-
particles on the quercetin uptake into cancer cells by using
the inverted ﬂuorescence microscopy. It is noted that upon
binding and chemical crosslinking within unknown protein
molecules in cells, the ﬂuorescence of quercetin could be
observed and detected [26]. As shown in Fig. 4, the
apparent differences of drug accumulation in cancer cells
were observed in the absence and presence of Ni nano-
particles. The cellular ﬂuorescence in the Ni nanoparticles-
treated system (Fig. 4b) is much higher than that with free
of Ni nanoparticles (Fig. 4a). Hence, these Ni nanoparticles
could remarkably facilitate the relative drug uptake and
accumulation into SMMC-7721 cancer cells and could thus
act as an efﬁcient agent to enhance drug delivery.
Meanwhile, our electrochemical studies also provide the
fresh evidence for the remarkable enhancement effect of the
Ni nanoparticles in the drug uptake of quercetin in cancer
cells. It is already known that quercetin (i.e., 3,30,40,5-7-
pentahydroxyﬂavone), a chemical cousin of the glycoside
rutin, is a unique ﬂavonoid that has been extensively studied
for its multiple effects as anticancer drug. In the present
study, we have utilized the differential pulse voltammetry
(DPV) to explore the effect of quercetin alone and quercetin
in the presence of Ni nanoparticles on the drug uptake of
relevant cancer cells. It is observed that with the anticancer
drug quercetin as the electrochemical probe, the drug
uptake efﬁciency for different cancer cells could be probed
by the differential pulse voltammetry (DPV) technique. As
we know, when different cells treated with quercetin, the
unadsorbed drug molecules are still in the environmental
solution, and the electrochemical response of this part of the
molecules can be readily detected. Thus, the quercetin
residue (unadsorbed quercetin) can be adopted as the ref-
erential value of the cellular uptake efﬁciency.
As shown in Fig. 5, the results of electrochemical study
of the amount of quercetin residues outside SMMC-7721
Scheme 1 Possible mechanism for quercetin uptake into SMMC-
7721 cells via Ni nanoparticle-mediated endocytosis
Fig. 4 Inverted ﬂuorescence
micrographs of SMMC-7721
cells after incubation with a
5.0 lmol/L of quercetin, and b
5.0 lmol/L of quercetin in the
presence of Ni nanoparticles
(2.0 lg/mL) at 37 C for 1 h.
The scale bar represents 10 lm
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room temperature illustrate that the DPV peak currents of
quercetin residue outside SMMC-7721 cells show an evi-
dent decrease after treating the SMMC-7721 cells with
quercetin for 2 and 6 h. Compared with that of the original
concentration of quercetin (50 lM), the peak current of
quercetin in the culture media decreased by 25% after a 2 h
culture, whereas it decreased by 48% when exposed toge-
ther with Ni nanoparticles. These results indicated that the
quercetin residue outside the SMMC-7721 cells in the
presence of Ni nanoparticles decreased more apparently
than that in the absence of Ni nanoparticles. In addition, the
decrease percentages of the peak current increased with the
increasing incubation time. So it could be deduced that
after coculture with cancer cells, the quercetin in the cul-
ture media could be admitted in cancer cells by endocy-
tosis, which led to the remarkable decrease of the peak
current.
After adding the Ni nanoparticles, apparently more
considerable changes of the electrochemical response of
quercetin residue outside SMMC-7721 cells were observed
than that in the absence of Ni nanoparticles, suggesting that
much more quercetin molecules could be diffused into the
relative cancer cells in the presence of Ni nanoparticles,
which demonstrated that Ni nanoparticles can efﬁciently
enhance the permeation and uptake of quercetin into
SMMC-7721 cancer cells.
Cytotoxicity Evaluation
On the basis of these observations, the cytotoxicity sup-
pression effect of quercetin on SMMC-7721 cells in the
absence and presence of Ni nanoparticles has been further
explored by MTT assay. As shown in Fig. 6, our studies
indicate that inhibition efﬁciency of cancer cell prolifera-
tion in vitro could be remarkably improved in the presence
of quercetin together with Ni nanoparticles when compared
with either relevant quercetin control or Ni nanoparticles
alone, where the inhibition rate of Ni nanoparticles alone to
cancer cells is only 9.8%, but the relevant inhibition efﬁ-
ciency was improved from 13.8% (25 lmol/L of quercetin)
to 36.7% (25 lmol/L of quercetin in the presence of Ni
nanoparticles), and from 28.3% (50 lmol/L of quercetin)
to 46.9% (50 lmol/L of quercetin in the presence of Ni
nanoparticles). The t-test results suggest that it has great
statistical difference when compared to the controls
(p\0.05). These results show that quercetin together with
Ni nanoparticles could inhibit cancer cell proliferation
more efﬁciently than that caused by the single addition of
quercetin and Ni nanoparticles, which indicates that Ni
nanoparticles and quercetin have synergic effect on inhib-
iting the proliferation of cancer cells.
The rational behind this may be attributed to that the
functionalized Ni nanoparticles could efﬁciently improve
the penetration of the drug quercetin into the cell mem-
brane, i.e., appropriate concentration of Ni nanoparticles
can effectively facilitate the permeation and uptake of
quercetin and increase the accumulation of quercetin in
cancer cells. Hence, it appears that when SMMC-7721
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it shows greatly efﬁcient quercetin uptake via introduction
by functionalized Ni nanoparticles.
RT-CES Assay
Unlike traditional end-point assays the RT-CES readout of
impedance is non-invasive and could continuously and
quantitatively provide a dynamic measurement of the
cytotoxic activity. The time resolution in the assay pro-
cesses provides high content information regarding the
extent of the cytotoxicity in addition to the exact time,
while the cytotoxicity takes place at different effect to
ratio. Cell Index (CI) is used to represent cell status based
on the measured electrical impedance [22]. The calculation
of frequency dependent electrode impedance with or
without cells present in the wells and corresponding CI
value has been described in the literature [22]. In general,
under the same physiologic conditions, CI value depends
on the number of cells attached to the electrodes: If no cells
are present on the electrodes, CI value is 0. The more cells
attached to the electrodes (e.g., an increase in cell adhesion
or cell spread), the higher the CI value obtained. All the
factors that affect the number of cells will result in the
change in CI value, e.g., cell proliferation will induce more
cells to attach to the sensors and lead to a higher CI value.
On the other hand, cell death or toxicity induced cell
detachment will result in a lower CI value.
Based on these considerations, the effect of cellular
interaction with Ni nanoparticles and/or quercetin have
been further explored with RT-CES assay, and our results
are consistent with those of our microscopy and electro-
chemical studies as well as MTT assay. As shown in Fig. 7,
little effect was observed for 2.0 lg/mL of Ni nanoparticles
on SMMC-7721 cancer cells (curve B) compared to the
control cells alone (curve A). However, 50 lmol/L of
quercetin (curve C) can greatly inhibit the cell proliferation
in vitro. When 50 lmol/L of quercetin and 2.0 lg/mL of
Ni nanoparticles were coapplied to the system, the cyto-
toxicity suppression of quercetin on cancer cells was fur-
ther enhanced (curve D), which was well in agreement with
that determined by MTT assay. These observations dem-
onstrate that the synergistic effect on cell proliferation
suppression between Ni nanoparticles and quercetin could
take place, i.e., Ni nanoparticles could efﬁciently facilitate
the cellular drug uptake into the cancer cells to increase the
drug accumulation and thus inhibit the cell proliferation.
Conclusion
In summary, in this study the cellular effect and in vitro
cytotoxicity of SMMC-7721 cancer cells treated with
anticancer agents accompanying with functionalized Ni
nanoparticles capped with positively charged tetrahepty-
lammonium have been investigated. The morphologies of
SMMC-7721 cancer cells in response to various treatments
have been explored by microscopy techniques. The
enhancement effect of these Ni nanoparticles on the drug
uptake of quercetin on SMMC-7721 cancer cells has been
observed and their relevant effects on cell proliferation have
been evaluated by MTT and RT-CES assay. The results
suggest that Ni nanoparticles and quercetin have synergic
effect on SMMC-7721 cells, and Ni nanoparticles can efﬁ-
ciently enhance the permeation and uptake of quercetin into
cancer cells, implying the greatpotential ofNinanoparticles
in cancer biomedical and chemotherapeutic applications.
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